179 related articles for article (PubMed ID: 29339396)
1. Efficacy of Apramycin against Multidrug-Resistant Acinetobacter baumannii in the Murine Neutropenic Thigh Model.
Kang AD; Smith KP; Berg AH; Truelson KA; Eliopoulos GM; McCoy C; Kirby JE
Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29339396
[TBL] [Abstract][Full Text] [Related]
2. Invitro Apramycin Activity against multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa.
Kang AD; Smith KP; Eliopoulos GM; Berg AH; McCoy C; Kirby JE
Diagn Microbiol Infect Dis; 2017 Jun; 88(2):188-191. PubMed ID: 28341099
[TBL] [Abstract][Full Text] [Related]
3. Identification and bioevaluation of SRI-12742 as an antimicrobial agent against multidrug-resistant Acinetobacter baumannii.
Shukla M; Soni I; Matsuyama K; Tran T; Tanga M; Gong L; Chopra S
Int J Antimicrob Agents; 2018 Jul; 52(1):22-27. PubMed ID: 29501820
[TBL] [Abstract][Full Text] [Related]
4. fAUC/MIC is the most predictive pharmacokinetic/pharmacodynamic index of colistin against Acinetobacter baumannii in murine thigh and lung infection models.
Dudhani RV; Turnidge JD; Nation RL; Li J
J Antimicrob Chemother; 2010 Sep; 65(9):1984-90. PubMed ID: 20573659
[TBL] [Abstract][Full Text] [Related]
5. Characterizing in vivo pharmacodynamics of carbapenems against Acinetobacter baumannii in a murine thigh infection model to support breakpoint determinations.
Macvane SH; Crandon JL; Nicolau DP
Antimicrob Agents Chemother; 2014; 58(1):599-601. PubMed ID: 24165174
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and Pharmacodynamics of Minocycline against Acinetobacter baumannii in a Neutropenic Murine Pneumonia Model.
Zhou J; Ledesma KR; Chang KT; Abodakpi H; Gao S; Tam VH
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28264853
[TBL] [Abstract][Full Text] [Related]
7. In Vivo Pharmacodynamic Target Investigation of Two Bacterial Topoisomerase Inhibitors, ACT-387042 and ACT-292706, in the Neutropenic Murine Thigh Model against Streptococcus pneumoniae and Staphylococcus aureus.
Lepak AJ; Seiler P; Surivet JP; Ritz D; Kohl C; Andes DR
Antimicrob Agents Chemother; 2016 Jun; 60(6):3626-32. PubMed ID: 27044547
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of apramycin activity against carbapenem-resistant and -susceptible strains of Enterobacteriaceae.
Smith KP; Kirby JE
Diagn Microbiol Infect Dis; 2016 Dec; 86(4):439-441. PubMed ID: 27745736
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic/pharmacodynamic evaluation of sulbactam against Acinetobacter baumannii in in vitro and murine thigh and lung infection models.
Yokoyama Y; Matsumoto K; Ikawa K; Watanabe E; Shigemi A; Umezaki Y; Nakamura K; Ueno K; Morikawa N; Takeda Y
Int J Antimicrob Agents; 2014 Jun; 43(6):547-52. PubMed ID: 24796218
[TBL] [Abstract][Full Text] [Related]
10. Anti-multidrug-resistant Acinetobacter baumannii activity of DS-8587: In vitro activity and in vivo efficacy in a murine calf muscle infection model.
Higuchi S; Kurosaka Y; Uoyama S; Yoshida K; Chiba M; Ishii C; Fujikawa K; Karibe Y; Hoshino K
J Infect Chemother; 2014 May; 20(5):312-6. PubMed ID: 24594453
[TBL] [Abstract][Full Text] [Related]
11. New pharmacokinetic/pharmacodynamic studies of systemically administered colistin against Pseudomonas aeruginosa and Acinetobacter baumannii in mouse thigh and lung infection models: smaller response in lung infection.
Cheah SE; Wang J; Nguyen VT; Turnidge JD; Li J; Nation RL
J Antimicrob Chemother; 2015 Dec; 70(12):3291-7. PubMed ID: 26318190
[TBL] [Abstract][Full Text] [Related]
12. Elucidating the Pharmacokinetics/Pharmacodynamics of Aerosolized Colistin against Multidrug-Resistant Acinetobacter baumannii and Klebsiella pneumoniae in a Mouse Lung Infection Model.
Lin YW; Zhou QT; Han ML; Chen K; Onufrak NJ; Wang J; Turnidge JD; Howden BP; Forrest A; Chan HK; Li J
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29229637
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of Humanized Exposures of Cefiderocol (S-649266) against a Diverse Population of Gram-Negative Bacteria in a Murine Thigh Infection Model.
Monogue ML; Tsuji M; Yamano Y; Echols R; Nicolau DP
Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28848004
[TBL] [Abstract][Full Text] [Related]
14. [Assessment of efficacies of imipenem, cefoperazone-sulbactam and cefepime in rats with experimental thigh abscess model with multidrug resistant and susceptible Acinetobacter baumannii strains].
Yıldırım MI; Tuğrul HM
Mikrobiyol Bul; 2011 Jul; 45(3):422-9. PubMed ID: 21935775
[TBL] [Abstract][Full Text] [Related]
15. In vivo pharmacokinetics and pharmacodynamics of the lantibiotic NAI-107 in a neutropenic murine thigh infection model.
Lepak AJ; Marchillo K; Craig WA; Andes DR
Antimicrob Agents Chemother; 2015 Feb; 59(2):1258-64. PubMed ID: 25512404
[TBL] [Abstract][Full Text] [Related]
16. In vitro pharmacodynamics of human-simulated exposures of ampicillin/sulbactam, doripenem and tigecycline alone and in combination against multidrug-resistant Acinetobacter baumannii.
Housman ST; Hagihara M; Nicolau DP; Kuti JL
J Antimicrob Chemother; 2013 Oct; 68(10):2296-304. PubMed ID: 23710070
[TBL] [Abstract][Full Text] [Related]
17. Comparative Pharmacodynamics of Telavancin and Vancomycin in the Neutropenic Murine Thigh and Lung Infection Models against Staphylococcus aureus.
Lepak AJ; Zhao M; Andes DR
Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28416551
[TBL] [Abstract][Full Text] [Related]
18.
Lepak AJ; Zhao M; VanScoy B; Taylor DS; Ellis-Grosse E; Ambrose PG; Andes DR
Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28396549
[TBL] [Abstract][Full Text] [Related]
19. In Vitro Activities of Novel Antimicrobial Combinations against Extensively Drug-Resistant Acinetobacter baumannii.
Córdoba J; Coronado-Álvarez NM; Parra D; Parra-Ruiz J
Antimicrob Agents Chemother; 2015 Dec; 59(12):7316-9. PubMed ID: 26369956
[TBL] [Abstract][Full Text] [Related]
20. Novel Engineered Peptides of a Phage Lysin as Effective Antimicrobials against Multidrug-Resistant Acinetobacter baumannii.
Thandar M; Lood R; Winer BY; Deutsch DR; Euler CW; Fischetti VA
Antimicrob Agents Chemother; 2016 May; 60(5):2671-9. PubMed ID: 26856847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]